カテゴリー： Transparency Market Research, 世界, 医療/バイオ

一酸化窒素吸入デリバリーシステムの世界市場（2022～2031）：種類別、用途別

◆英語タイトル：Inhaled Nitric Oxide Delivery System Market (Type: Pediatric and Adult; Application: Hypoxemic Respiratory Failure Treatment, Acute Vasoreactivity Testing, Pulmonary Hypertension Treatment, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが発行した調査報告書（TMR23AP141）◆商品コード：TMR23AP141
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年1月10日
◆ページ数：182
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥869,250見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,319,250見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,769,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の本調査レポートでは、一酸化窒素吸入デリバリーシステムの世界市場について総合的に分析し、今後の市場動向を予測しています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（小児用、成人用）分析、用途別（低酸素性呼吸不全治療、急性血管反応検査、肺高血圧症治療、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目が整理されています。また、本書内には、Mallinckrodt、Santair AE、VERO Biotech、Linde plc、Beyond Air, Inc.、SLE、Bellerophon Therapeutics、Air Liquide Healthcare、International Biomedical、Circassia Pharmaceuticalsなどの企業情報が含まれています。
・序論
・仮定＆調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の一酸化窒素吸入デリバリーシステム市場規模：種類別
- 小児用一酸化窒素吸入デリバリーシステムの市場規模
- 成人用一酸化窒素吸入デリバリーシステムの市場規模
・世界の一酸化窒素吸入デリバリーシステム市場規模：用途別
- 低酸素性呼吸不全治療における市場規模
- 急性血管反応検査における市場規模
- 肺高血圧症治療における市場規模
- その他用途における市場規模
・世界の一酸化窒素吸入デリバリーシステム市場規模：エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の一酸化窒素吸入デリバリーシステム市場規模：地域別
- 北米の一酸化窒素吸入デリバリーシステム市場規模
- ヨーロッパの一酸化窒素吸入デリバリーシステム市場規模
- アジア太平洋の一酸化窒素吸入デリバリーシステム市場規模
- 中南米のアルミニウムスラグ市場規模
- 中東・アフリカのアルミニウムスラグ市場規模
・競争状況

Inhaled Nitric Oxide Delivery System Market – Scope of Report
TMR’s report on the global inhaled nitric oxide delivery system market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global inhaled nitric oxide delivery system market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global inhaled nitric oxide delivery system market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the inhaled nitric oxide delivery system market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global inhaled nitric oxide delivery system market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global inhaled nitric oxide delivery system market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global inhaled nitric oxide delivery system market.

The report delves into the competitive landscape of the global inhaled nitric oxide delivery system market. Key players operating in the global inhaled nitric oxide delivery system market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global inhaled nitric oxide delivery system market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market inhaled nitric oxide delivery system.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Inhaled Nitric Oxide Delivery System Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Overview of applications of iNO in pediatric as well as in adults
    5.2. Technological Advancements
    5.3. Disease prevalence and incidence globally with key countries
    5.4. Covid-19 Impact Analysis
6. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Type, 2017–2031
        6.3.1. Pediatric
        6.3.2. Adult
    6.4. Market Attractiveness Analysis, by Type
7. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Hypoxemic Respiratory Failure Treatment
        7.3.2. Acute Vasoreactivity Testing
        7.3.3. Pulmonary Hypertension (PH) Treatment
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Ambulatory Surgical Centers
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East
    9.3. Market Attractiveness Analysis, by Region
10. North America Inhaled Nitric Oxide Delivery System Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Type, 2017–2031
        10.2.1. Pediatric
        10.2.2. Adult
    10.3. Market Value Forecast, by Application, 2017–2031
        10.3.1. Hypoxemic Respiratory Failure Treatment
        10.3.2. Acute Vasoreactivity Testing
        10.3.3. Pulmonary Hypertension (PH) Treatment
        10.3.4. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Ambulatory Surgical Centers
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Inhaled Nitric Oxide Delivery System Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Type, 2017–2031
        11.2.1. Pediatric
        11.2.2. Adult
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Hypoxemic Respiratory Failure Treatment
        11.3.2. Acute Vasoreactivity Testing
        11.3.3. Pulmonary Hypertension (PH) Treatment
        11.3.4. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Ambulatory Surgical Centers
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Inhaled Nitric Oxide Delivery System Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Type, 2017–2031
        12.2.1. Pediatric
        12.2.2. Adult
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Hypoxemic Respiratory Failure Treatment
        12.3.2. Acute Vasoreactivity Testing
        12.3.3. Pulmonary Hypertension (PH) Treatment
        12.3.4. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Ambulatory Surgical Centers
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Inhaled Nitric Oxide Delivery System Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Type, 2017–2031
        13.2.1. Pediatric
        13.2.2. Adult
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Hypoxemic Respiratory Failure Treatment
        13.3.2. Acute Vasoreactivity Testing
        13.3.3. Pulmonary Hypertension (PH) Treatment
        13.3.4. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Ambulatory Surgical Centers
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East Inhaled Nitric Oxide Delivery System Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Type, 2017–2031
        14.2.1. Pediatric
        14.2.2. Adult
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Hypoxemic Respiratory Failure Treatment
        14.3.2. Acute Vasoreactivity Testing
        14.3.3. Pulmonary Hypertension (PH) Treatment
        14.3.4. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Ambulatory Surgical Centers
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & South Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2021
    15.3. Company Profiles
        15.3.1. Mallinckrodt
            15.3.1.1. Company Overview
            15.3.1.2. Financial Overview
            15.3.1.3. Product Portfolio
            15.3.1.4. Business Strategies
            15.3.1.5. Recent Developments
        15.3.2. Santair AE
            15.3.2.1. Company Overview
            15.3.2.2. Financial Overview
            15.3.2.3. Product Portfolio
            15.3.2.4. Business Strategies
            15.3.2.5. Recent Developments
        15.3.3. VERO Biotech
            15.3.3.1. Company Overview
            15.3.3.2. Financial Overview
            15.3.3.3. Product Portfolio
            15.3.3.4. Business Strategies
            15.3.3.5. Recent Developments
        15.3.4. Linde plc
            15.3.4.1. Company Overview
            15.3.4.2. Financial Overview
            15.3.4.3. Product Portfolio
            15.3.4.4. Business Strategies
            15.3.4.5. Recent Developments
        15.3.5. Beyond Air, Inc.
            15.3.5.1. Company Overview
            15.3.5.2. Financial Overview
            15.3.5.3. Product Portfolio
            15.3.5.4. Business Strategies
            15.3.5.5. Recent Developments
        15.3.6. SLE
            15.3.6.1. Company Overview
            15.3.6.2. Financial Overview
            15.3.6.3. Product Portfolio
            15.3.6.4. Business Strategies
            15.3.6.5. Recent Developments
        15.3.7. Bellerophon Therapeutics
            15.3.7.1. Company Overview
            15.3.7.2. Financial Overview
            15.3.7.3. Product Portfolio
            15.3.7.4. Business Strategies
            15.3.7.5. Recent Developments
        15.3.8. Air Liquide Healthcare
            15.3.8.1. Company Overview
            15.3.8.2. Financial Overview
            15.3.8.3. Product Portfolio
            15.3.8.4. Business Strategies
            15.3.8.5. Recent Developments
        15.3.9. International Biomedical
            15.3.9.1. Company Overview
            15.3.9.2. Financial Overview
            15.3.9.3. Product Portfolio
            15.3.9.4. Business Strategies
            15.3.9.5. Recent Developments
        15.3.10. Circassia Pharmaceuticals
            15.3.10.1. Company Overview
            15.3.10.2. Financial Overview
            15.3.10.3. Product Portfolio
            15.3.10.4. Business Strategies
            15.3.10.5. Recent Developments

List of Tables

Table 01: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 02: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 03: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 07: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 08: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 11: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 12: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 15: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 16: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 19: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Material 2017‒2031

Table 20: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 23: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 24: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 一酸化窒素吸入デリバリーシステムの世界市場（2022～2031）：種類別、用途別(Inhaled Nitric Oxide Delivery System Market (Type: Pediatric and Adult; Application: Hypoxemic Respiratory Failure Treatment, Acute Vasoreactivity Testing, Pulmonary Hypertension Treatment, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 再利用型蘇生器の世界市場（2022～2031）：製品別、年齢層別
  • 乳児用蘇生器の世界市場（2022～2031）：製品別、種類別
  • 大容量ネブライザーの世界市場（2022～2031）：製品種類別、容量別
  • パスオーバー型加湿器の世界市場（2022～2031）：製品種類別
  • 医療用酸素ボンベの世界市場（2022～2031）：製品種類別、エンドユーザー別

    • ◆H&Iグローバルリサーチのお客様（例）◆